Compounds > s-(3-hydroxypropyl)cysteine n-acetate
Page last updated: 2024-09-03

s-(3-hydroxypropyl)cysteine n-acetate and Cardiovascular Diseases

s-(3-hydroxypropyl)cysteine n-acetate has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abplanalp, W; Becher, C; Bhatnagar, A; Chugh, A; Ciszewski, T; Conklin, DJ; DeFilippis, A; DeJarnett, N; Hamzeh, I; Higdon, D; McCracken, J; Myers, JA; O'Toole, TE; Prabhu, SD; Rai, SN; Ramos, KS; Riggs, DW; Srivastava, S; Tollerud, DJ; Wagner, S; Wyatt, B; Xie, Z; Yeager, R1

Other Studies

1 other study(ies) available for s-(3-hydroxypropyl)cysteine n-acetate and Cardiovascular Diseases

ArticleYear
Acrolein exposure is associated with increased cardiovascular disease risk.
    Journal of the American Heart Association, 2014, Aug-06, Volume: 3, Issue:4

    Topics: Acetylcysteine; Acrolein; Adult; Aged; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Humans; Kentucky; Leukocytes; Linear Models; Male; Middle Aged; Platelet Activation; Smoking

2014